Cancer Research Targets Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grushko, T. A.
Right arrow Articles by Olopade, O. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grushko, T. A.
Right arrow Articles by Olopade, O. I.
[Cancer Research 62, 1481-1488, March 1, 2002]
© 2002 American Association for Cancer Research

Molecular Biology and Genetics

Molecular-Cytogenetic Analysis of HER-2/neu Gene in BRCA1-associated Breast Cancers1

Tatyana A. Grushko, M. Anne Blackwood, Phil L. Schumm, Fitsum G. Hagos, Moses O. Adeyanju, Michael D. Feldman, Melinda O. Sanders, Barbara L. Weber and Olufunmilayo I. Olopade2

Section of Hematology/Oncology, Department of Medicine, Committees on Genetics and Cancer Biology [T. A. G., F. G. H., O. I. O], and Department of Health Studies [P. L. S.], University of Chicago, Chicago, Illinois 60637-1463; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021 [M. A. B.]; Laboratory Corporation of America, Elmhurst, Illinois 60126-1539 [M. O. A.]; Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia Pennsylvania 19104-6021 [M. D. F., M. O. S.]; and Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 9104–6160 [B. L. W.]

The BRCA1 tumor suppressor gene and the HER-2/neu oncogene are located in close proximity on the long arm of chromosome 17 (17q11–21). Absence of BRCA1 or functional overexpression of the HER-2/neu gene presumably contributes to the somatic phenotype of breast cancer in premenopausal women, characterized by unfavorable prognostic features such as high tumor grade, hormone receptor negativity, and high proliferation rate. To examine whether amplification of HER-2/neu contributes to the aggressive biology of BRCA1-associated tumors, we have performed fluorescence in situ hybridization on formalin-fixed paraffin-embedded breast tumor tissue sections from 53 BRCA1 mutation carriers and 41 randomly selected, age-matched sporadic breast cancer cases. Although BRCA1-associated and sporadic tumors were equally likely (19% versus 22%) to exhibit HER-2/neu amplification [defined as a ratio of HER-2/neu copies to chromosome 17 centromere (CEP17) copies >= 2], 6 (15%) of the sporadic tumors were highly amplified (defined as a ratio >= 5) versus none of the BRCA1-associated tumors (P = 0.048). HER-2 protein overexpression as measured by immunohistochemical analysis was not observed among the BRCA1-associated cases (P = 0.042). Four of 21 (19%) sporadic tumors exhibited strong membranous staining of HER-2 (intensity level of 3+) as compared with 0 of 39 BRCA1-associated tumors. Our data suggest that a germ-line mutation in the BRCA1 tumor suppressor gene is associated with a significantly lower level of HER-2/neu amplification. Thus, it is possible that BRCA1-associated and HER-2/neu-highly amplified tumors progress through distinct molecular pathways, and the aggressive pathological features of BRCA1-associated tumors appear unrelated to amplification of the adjacent HER-2/neu oncogene.




This article has been cited by other articles:


Home page
 Clin. Chem.Home page
C.-H. Yeh, W. A. Whitmire III, and M. Albitar
Liquid-Based Fluorescence In Situ Hybridization Assay for Detection of ERBB2 Gene Amplification in Patients with Breast Cancer
Clin. Chem., November 1, 2008; 54(11): 1831 - 1839.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. Melchor and J. Benitez
An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes
Carcinogenesis, August 1, 2008; 29(8): 1475 - 1482.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. Campos, C. Prior, F. Warleta, I. Zudaire, J. Ruiz-Mora, R. Catena, A. Calvo, and J. J. Gaforio
Phenotypic and Genetic Characterization of Circulating Tumor Cells by Combining Immunomagnetic Selection and FICTION Techniques
J. Histochem. Cytochem., July 1, 2008; 56(7): 667 - 675.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M Tretiakova, M Turkyilmaz, T Grushko, M Kocherginsky, C Rubin, B Teh, and X J Yang
Topoisomerase II{alpha} in Wilms' tumour: gene alterations and immunoexpression
J. Clin. Pathol., December 1, 2006; 59(12): 1272 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Dal Lago, V. Durbecq, C. Desmedt, R. Salgado, T. Verjat, L. Lespagnard, Y. Ma, I. Veys, A. Di Leo, C. Sotiriou, et al.
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer.
Mol. Cancer Ther., October 1, 2006; 5(10): 2572 - 2579.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. A. Carey, C. M. Perou, C. A. Livasy, L. G. Dressler, D. Cowan, K. Conway, G. Karaca, M. A. Troester, C. K. Tse, S. Edmiston, et al.
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
JAMA, June 7, 2006; 295(21): 2492 - 2502.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Wei, T. A. Grushko, J. Dignam, F. Hagos, R. Nanda, L. Sveen, J. Xu, J. Fackenthal, M. Tretiakova, S. Das, et al.
BRCA1 Promoter Methylation in Sporadic Breast Cancer Is Associated with Reduced BRCA1 Copy Number and Chromosome 17 Aneusomy
Cancer Res., December 1, 2005; 65(23): 10692 - 10699.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Ma, L. Lespagnard, V. Durbecq, M. Paesmans, C. Desmedt, M. Gomez-Galdon, I. Veys, F. Cardoso, C. Sotiriou, A. Di Leo, et al.
Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice
Clin. Cancer Res., June 15, 2005; 11(12): 4393 - 4399.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. A. Grushko, J. J. Dignam, S. Das, A. M. Blackwood, C. M. Perou, K. K. Ridderstrale, K. N. Anderson, M.-J. Wei, A. J. Adams, F. G. Hagos, et al.
MYC Is Amplified in BRCA1-Associated Breast Cancers
Clin. Cancer Res., January 15, 2004; 10(2): 499 - 507.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Palacios, E. Honrado, A. Osorio, A. Cazorla, D. Sarrio, A. Barroso, S. Rodriguez, J. C. Cigudosa, O. Diez, C. Alonso, et al.
Immunohistochemical Characteristics Defined by Tissue Microarray of Hereditary Breast Cancer Not Attributable to BRCA1 or BRCA2 Mutations: Differences from Breast Carcinomas Arising in BRCA1 and BRCA2 Mutation Carriers
Clin. Cancer Res., September 1, 2003; 9(10): 3606 - 3614.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
P. Lal, P. A. Salazar, M. Ladanyi, and B. Chen
Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas without HER-2/neu Gene Amplification
J. Mol. Diagn., August 1, 2003; 5(3): 155 - 159.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Dellas, J. Torhorst, R. Gaudenz, M. J. Mihatsch, and H. Moch
DNA Copy Number Changes in Cervical Adenocarcinoma
Clin. Cancer Res., August 1, 2003; 9(8): 2985 - 2991.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, et al.
Repeated observation of breast tumor subtypes in independent gene expression data sets
PNAS, July 8, 2003; 100(14): 8418 - 8423.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.